Supplementary Figure S2 showing that removal of mutant TP53 has no impact on survival, proliferation, mitochondrial content and ROS levels in diverse human cancer cell lines
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: